Search details
1.
Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responses.
Proc Natl Acad Sci U S A
; 110(35): 14330-5, 2013 Aug 27.
Article
in English
| MEDLINE | ID: mdl-23940329
2.
Impact of preexisting memory to seasonal A/H1N1 influenza virus on the immune response following vaccination against avian A/H5N1 virus.
Eur J Immunol
; 43(3): 641-8, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23238926
3.
Public health perspective of a pentavalent meningococcal vaccine combining antigens of MenACWY-CRM and 4CMenB.
J Infect
; 85(5): 481-491, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36087745
4.
Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults.
Hum Vaccin Immunother
; 18(1): 1981085, 2022 12 31.
Article
in English
| MEDLINE | ID: mdl-34614379
5.
A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study.
Vaccine
; 39(45): 6628-6636, 2021 10 29.
Article
in English
| MEDLINE | ID: mdl-34635373
6.
One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series.
J Travel Med
; 23(3)2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26994987
7.
Five year follow-up after primary vaccination against tick-borne encephalitis in children.
Vaccine
; 33(15): 1824-9, 2015 Apr 08.
Article
in English
| MEDLINE | ID: mdl-25728316
8.
A new strategy for preparing a tailored meningococcal ACWY conjugate vaccine for clinical testing.
Vaccine
; 38(23): 3930-3933, 2020 05 13.
Article
in English
| MEDLINE | ID: mdl-32299720
9.
A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59®: adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy adults.
Hum Vaccin Immunother
; 10(1): 92-9, 2014.
Article
in English
| MEDLINE | ID: mdl-24047817
10.
Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza.
Expert Opin Biol Ther
; 13(1): 121-35, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23189937
11.
Ex vivo analysis of human memory B lymphocytes specific for A and B influenza hemagglutinin by polychromatic flow-cytometry.
PLoS One
; 8(8): e70620, 2013.
Article
in English
| MEDLINE | ID: mdl-23976947
12.
Assessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects.
Clin Vaccine Immunol
; 19(12): 1943-8, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-23081815
13.
Phase III, randomized controlled trial to evaluate lot consistency of a trivalent subunit egg-based influenza vaccine in adults.
Vaccine
; 30(35): 5285-92, 2012 Jul 27.
Article
in English
| MEDLINE | ID: mdl-22659448
14.
Immunogenicity, safety, and tolerability of two trivalent subunit inactivated influenza vaccines: a phase III, observer-blind, randomized, controlled multicenter study.
Viral Immunol
; 25(3): 216-25, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22691101
15.
A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses.
Clin Ther
; 32(13): 2186-97, 2010 Dec.
Article
in English
| MEDLINE | ID: mdl-21316535
16.
A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly.
Clin Vaccine Immunol
; 17(11): 1817-9, 2010 Nov.
Article
in English
| MEDLINE | ID: mdl-20810680
17.
MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis.
Influenza Other Respir Viruses
; 2(6): 243-9, 2008 Nov.
Article
in English
| MEDLINE | ID: mdl-19453401
18.
Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene.
Clin Vaccine Immunol
; 13(9): 1010-3, 2006 Sep.
Article
in English
| MEDLINE | ID: mdl-16960112
Results
1 -
18
de 18
1
Next >
>>